Track topics on Twitter Track topics that are important to you
Eli Lilly set to acquire dermatological drugs developer, Dermira, in an $1.1bn all-cash deal, adding commercial and late-stage drugs to its portfolio.
Original Article: Lilly acquires Dermira for $1.1bn, expands dermatology portfolioNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...